NRG DT001

Primary Category:

Radiation Oncology, Treatment Protocols

Disease Category:

Sarcoma

Status:

Open

A Phase Ib Trial of Neoadjuvant AMG 232 (KRT-232) Concurrent with Preoperative Radiotherapy in Wild-Type P53 Soft Tissue Sarcoma (STS)

NCT#03217266

Effective November 18, 2021, NRG DT001, Cohort A , (extremity/body wall) is permanently closed to accrual.

Effective, 04/24/20, NRG DT001, Cohort B, is reactivated to Dose Level 2.